Drag a card by its title · ⚙ to size, swap or remove

The company

PepGen Inc.

PEPG · Nasdaq

Health CareBiotechnologyAbove a falling average

PEPG stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 30 weeks. It is 16.4% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Above a falling average
Weeks in an uptrend: out for 30
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $119K
Officials’ trades on record: 0
Institutions holding: 69 (-19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months4

Buyers · sellers0 · 4

Who	Did	Shares	Traded
Kasra KasraianChief Technical Officer	sold	1,233at $1.41	21 May 2026filed 26 May 2026
James G. McArthurPresident and CEO	sold	5,144at $6.23	4 Mar 2026filed 6 Mar 2026
James G. McArthurPresident and CEO	sold	131at $6.33	4 Mar 2026filed 6 Mar 2026
Noel DonnellyChief Financial Officer	sold	2,032at $6.23	4 Mar 2026filed 6 Mar 2026
Noel DonnellyChief Financial Officer	sold	52at $6.33	4 Mar 2026filed 6 Mar 2026
Paul StreckEVP, Head of R&D	sold	1,832at $6.23	4 Mar 2026filed 6 Mar 2026
Paul StreckEVP, Head of R&D	sold	47at $6.29	4 Mar 2026filed 6 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders69-19 on the quarter

New · exited8 · 26

Reported value$92.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	20,064,545$36.1M	00.0%
Commodore Capital LPunchanged · filed 14 Aug 2026	4,475,000$8.1M	00.0%
VIKING GLOBAL INVESTORS LPunchanged · filed 14 Aug 2026	3,482,434$6.3M	00.0%
Laurion Capital Management LPunchanged · filed 13 Aug 2026	2,750,855$5.0M	00.0%
ADAR1 Capital Management, LLCadded · filed 14 Aug 2026	2,591,085$4.7M	+983,447+61.2%
Vivo Capital, LLCunchanged · filed 14 Aug 2026	2,325,000$4.2M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	1,935,920$3.5M	-1,779−0.1%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026	1,786,765$3.2M	-292,378−14.1%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026	1,520,246$2.7M	+1,463,446+2576.5%
BlackRock, Inc.added · filed 7 Aug 2026	1,304,262$2.3M	+26,478+2.1%